Nephrolithiasis and loss of kidney function

Current Opinion in Nephrology and Hypertension

Volumn 22, Issue 4, 2013, Pages 390-396

  Keddis, Mira T ^a   Rule, Andrew D ^a  

^a MAYO CLINIC   (United States)

Author keywords

Chronic kidney disease; End stage renal disease; Glomerular filtration rate; Nephrolithiasis

Indexed keywords

CREATININE; STRUVITE; URIC ACID;

ACUTE KIDNEY FAILURE; CHRONIC KIDNEY DISEASE; COMORBIDITY; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE ASSOCIATION; GLOMERULUS FILTRATION RATE; HUMAN; HYDRONEPHROSIS; HYPERTENSION; ILEAL CONDUIT; KIDNEY DYSFUNCTION; KIDNEY FAILURE; KIDNEY FIBROSIS; KIDNEY PARENCHYMA; MICROALBUMINURIA; NEPHROLITHIASIS; NEUROGENIC BLADDER; OBESITY; PERCUTANEOUS NEPHROLITHOTOMY; PREDICTIVE VALUE; PRIORITY JOURNAL; RECURRENT INFECTION; RENAL REPLACEMENT THERAPY; REVIEW; RISK ASSESSMENT; SOLITARY KIDNEY; URIC ACID STONE; URINARY TRACT INFECTION;

ANIMALS; DISEASE PROGRESSION; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; NEPHROLITHIASIS; PREVALENCE; PROGNOSIS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84879227593     PISSN: 10624821     EISSN: 14736543     Source Type: Journal    
DOI: 10.1097/MNH.0b013e32836214b9     Document Type: Review

References (34)

1. Lotan Y. Economics and cost of care of stone disease. Adv Chronic Kidney Dis 2009; 16:5-10.
2. Stamatelou KK, Francis ME, Jones CA, et al. Time trends in reported prevalence of kidney stones in the United States. Kidney Int 2003; 63:1817-1823.
3. Sakhaee K, Maalouf NM, Sinnott B. Clinical review. Kidney stones 2012: pathogenesis, diagnosis, and management. J Clin Endocrinol Metab 2012; 97:1847-1860.
4. Sakhaee K. Nephrolithiasis as a systemic disorder. Curr Opin Nephrol Hypertens 2008; 17:304-309.
5. Gaudio KM, Siegel NJ, Hayslett JP, Kashgarian M. Renal perfusion and intratubular pressure during ureteral occlusion in the rat. Am J Physiol 1980; 238:F205-209.
6. Klahr S. Urinary tract obstruction. Semin Nephrol 2001; 21:133-145.
7. Klahr S, Morrissey J. Obstructive nephropathy and renal fibrosis: the role of bone morphogenic protein-7 and hepatocyte growth factor. Kidney Int Suppl 2003; 87:105-112.
8. Larsson PA, Cano M, Grenabo L, et al. Morphological lesions of the rat urinary tract induced by inoculation of mycoplasmas and other urinary tract pathogens. Urol Int 1989; 44:210-217.
9. Gupta M, Bolton DM, Gupta PN, Stoller ML. Improved renal function following aggressive treatment of urolithiasis and concurrent mild to moderate renal insufficiency. J Urol 1994; 152:1086-1090.
10. Evan AP, Lingeman JE, Coe FL, et al. Crystal-associated nephropathy in patients with brushite nephrolithiasis. Kidney Int 2005; 67:576-591.
11. Boonla C, Krieglstein K, Bovornpadungkitti S, et al. Fibrosis and evidence for epithelial-mesenchymal transition in the kidneys of patients with staghorn calculi. BJU Int 2011; 108:1336-1345.
12. Evan AP, Coe FL, Lingeman JE, et al. Renal crystal deposits and histopathology in patients with cystine stones. Kidney Int 2006; 69:2227-2235.
13. Gershman B, Sheth S, Dretler SP, et al. Relationship between glomerular filtration rate and 24-h urine composition in patients with nephrolithiasis. Urology 2012; 80:38-42.
14. El-Zoghby ZM, Lieske JC, Foley RN, et al. Urolithiasis and the risk of ESRD. Clin J Am Soc Nephrol 2012; 7:1409-1415.
15. Vupputuri S, Soucie JM, McClellan W, Sandler DP. History of kidney stones as a possible risk factor for chronic kidney disease. Ann Epidemiol 2004; 14:222-228.
16. Gillen DL, Worcester EM, Coe FL. Decreased renal function among adults with a history of nephrolithiasis: a study of NHANES III. Kidney Int 2005; 67:685-690.
17. Rule AD, Bergstralh EJ, Melton LJ 3rd, et al. Kidney stones and the risk for chronic kidney disease. Clin J Am Soc Nephrol 2009; 4:804-811.
18. Hippisley-Cox J, Coupland C. Predicting the risk of chronic kidney disease in men and women in England and Wales: prospective derivation and external validation of the QKidney Scores. BMC Fam Pract 2010; 11:49.
19. Kadlec AO, Greco KA, Fridirici ZC, et al. Effect of renal function on urinary mineral excretion and stone composition. Urology 2011; 78:744-747.
20. Chou YH, Li CC, Hsu H, et al. Renal function in patients with urinary stones of varying compositions. Kaohsiung J Med Sci 2011; 27:264-267.
21. Jungers P, Joly D, Barbey F, et al. ESRD caused by nephrolithiasis: prevalence, mechanisms, and prevention. Am J Kidney Dis 2004; 44:799-805.
22. Collins AJ, Foley RN, Herzog C, et al. US Renal Data System 2010 Annual Data Report. Am J Kidney Dis 2011; 57 (A8):e1-e526.
23. Alexander RT, Hemmelgarn BR, Wiebe N, et al. Kidney stones and kidney function loss: a cohort study. Br Med J 2012; 345:e5287.
24. Lorenz EC, Lieske JC, Vrtiska TJ, et al. Clinical characteristics of potential kidney donors with asymptomatic kidney stones. Nephrol Dial Transplant 2011; 26:2695-2700.
25. Naganuma T, Takemoto Y, Maeda S, et al. Chronic kidney disease in patients with ileal conduit urinary diversion. Exp Ther Med 2012; 4:962-966.
26. Saucier NA, Sinha MK, Liang KV, et al. Risk factors for CKD in persons with kidney stones: a case-control study in Olmsted County, Minnesota. Am J Kidney Dis 2010; 55:61-68.
27. Kuzgunbay B, Gul U, Turunc T, et al. Long-term renal function and stone recurrence after percutaneous nephrolithotomy in patients with renal insufficiency. J Endourol 2010; 24:305-308.
28. Akman T, Binbay M, Aslan R, et al. Long-term outcomes of percutaneous nephrolithotomy in 177 patients with chronic kidney disease: a single center experience. J Urol 2012; 187:173-177.
29. Ozden E, Mercimek MN, Bostanci Y, et al. Long-term outcomes of percutaneous nephrolithotomy in patients with chronic kidney disease: a single-center experience. Urology 2012; 79:990-994.
30. Bilen CY, Inci K, Kocak B, et al. Impact of percutaneous nephrolithotomy on estimated glomerular filtration rate in patients with chronic kidney disease. J Endourol 2008; 22:895-900.
31. Evan AP, Willis LR, Lingeman JE, McAteer JA. Renal trauma and the risk of long-term complications in shock wave lithotripsy. Nephron 1998; 78:1-8.
32. Eassa WA, Sheir KZ, Gad HM, et al. Prospective study of the long-term effects of shock wave lithotripsy on renal function and blood pressure. J Urol 2008; 179:964-968; discussion 968-969.
33. el-Assmy A, el-Nahas AR, Hekal IA, et al. Long-term effects of extracorporeal shock wave lithotripsy on renal function: our experience with 156 patients with solitary kidney. J Urol 2008; 179:2229-2232.
34. Carvalho M, Martin RL, Passos RC, Riella MC. Nephrectomy as a cause of chronic kidney disease in the treatment of urolithiasis: a case-control study. World J Urol 2012. [Epub ahead of print]. Diseases